Javier Martín Broto, M.D. Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2012
NCT02587169
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Broto, Javier Martín, M.D.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chondrosarcoma (Phase 2)

Leiomyosarcoma (Phase 2)

Liposarcoma (Phase 2)

Osteosarcoma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 4